// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

MISSED OPPORTUNITIES FOR DCD KIDNEY DONORS: EVALUATION OF WARM ISCHEMIC TIME AND ASSOCIATED FUNCTIONAL WARM ISCHEMIC TIME

Jeffrey Law - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

NOVEL DEVICE FOR RENAL COOLING DURING TRANSPLANTATION

Thomas Skinner - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

SURVEILLANCE OF POST CHEMOTHERAPY NON SEMINOMATOUS GERM CELL TUMOR (NSGCT) RESIDUAL (≤1CM) MASSES

Gregory Nason - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

A RETROSPECTIVE REVIEW OF PARTIAL ORCHIECTOMY AT THE PRINCESS MARGARET CANCER CENTRE

Gregory Nason - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Testicular cancer

N/A

ROLE OF ROUTINE BIOPSY AFTER RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

Ronald Kool - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Bladder Cancer

N/A

IMPLEMENTING AND EVALUATING THE EFFICACY OF AN ACUTE CARE UROLOGY MODEL OF CARE IN A LARGE COMMUNITY HOSPITAL

Abirami Kirubarajan - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

IN VITRO EVALUATION OF NOVEL SURFACE MODIFYING MOLECULES TO PREVENT BACTERIAL ADHESION TO UROLOGICAL DEVICES

Christopher Munday - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

SIMULTANEOUS VERSUS SEQUENTIAL RETROPERITONEAL AND THORACIC RESECTION OF POST CHEMOTHERAPY RESIDUAL MASSES IN PATIENTS WITH METASTATIC NON-SEMINOMATOUS GERM CELL TUMORS OF THE TESTIS

Gregory Nason - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Germ cell tumor

N/A

SOX2, A MASTER REGULATOR OF STEMNESS, IS OVEREXPRESSED IN TESTICULAR TISSUE OF MEN WITH SERTOLI CELL ONLY SYNDROME

Russell Hayden - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Infertility

N/A

OUTCOMES OF MEDICAL VS INTERVENTIONAL MANAGEMENT FOR ACUTE URETERAL COLIC IN EMERGENCY DEPARTMENT PATIENTS

Grant Innes - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

UTILIZATION OF PSYCHIATRIC RESOURCES PRIOR TO GENITOURINARY (GU) CANCER DIAGNOSIS: IMPLICATIONS FOR SURVIVAL OUTCOMES

Zachary Klaassen - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

ONE IN THE SAME? THE HISTOPATHOLOGICAL DIFFERENCES IN RADICAL VS DONOR NEPHRECTOMY SPECIMENS

Deepak Pruthi - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Renal disease

N/A

PREDICTORS OF BIOCHEMICAL RECURRENCE AFTER PRIMARY WHOLE GLAND CRYOTHERAPY FOR PROSTATE CANCER

Adam Kinnaird - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Prostate cancer

N/A

TUMOR CONTROL OUTCOMES OF SALVAGE CRYOTHERAPY FOR RADIORECURRENT PROSTATE CANCER AT MEDIAN 12 YEARS FOLLOW-UP

Shiva Nair - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Prostate cancer

N/A

MEDIAN 5-YEAR ONCOLOGICAL OUTCOMES OF SALVAGE HIGH INTENSITY FOCUSED ULTRASOUND FOR PROSTATE CANCER RECURRENCES AFTER PRIMARY RADIOTHERAPY

Shiva Nair - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Prostate cancer

N/A

DERIVATION AND VALIDATION OF TEXT SEARCH ALGORITHMS FOR RENAL AND ADRENAL LESION IDENTIFICATION IN RADIOLOGY TEXT REPORTS

Luke Lavallee - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease

Avi Friedman - European Congress of Endocrinology (ECE) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Specification of pituitary cell fates

Jacques Drouin - European Congress of Endocrinology (ECE) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pituitary adenomas

N/A

Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study

Rosario Pivonello - European Congress of Endocrinology (ECE) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Pituitary adenoma 4, ACTH-secreting

LCI699

Applying the Bradford Hill criteria to evaluate the association between hypoglycaemia and cardiovascular events/mortality (CVEM) [Data from meta-analysis (MA), Randomized Controlled Trials (RCTs), and observational outcome studies (OBS)]

Pendar Farahani - European Congress of Endocrinology (ECE) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved